Cel-Sci
CVM
#10585
Rank
โ‚ฌ24.52 M
Marketcap
1,39ย โ‚ฌ
Share price
3.85%
Change (1 day)
-86.59%
Change (1 year)

EPS for Cel-Sci (CVM)

EPS in 2026 (TTM): -4,47ย โ‚ฌ

According to Cel-Sci 's latest financial reports the company's current EPS (TTM) is -4,34ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -5,40ย โ‚ฌ an increase over its 2024 EPS that were of -13,18ย โ‚ฌ.

EPS history for Cel-Sci from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-4,47ย โ‚ฌ-17.26%
2025-5,40ย โ‚ฌ-59.05%
2024-13,18ย โ‚ฌ-30.09%
2023-18,85ย โ‚ฌ-16.09%
2022-22,46ย โ‚ฌ-3.33%
2021-23,24ย โ‚ฌ9.76%
2020-21,17ย โ‚ฌ15.49%
2019-18,33ย โ‚ฌ-62.03%
2018-48,29ย โ‚ฌ2.19%
2017-47,25ย โ‚ฌ-22.78%
2016-61,20ย โ‚ฌ-77.45%
2015-271,38ย โ‚ฌ-13.14%
2014-312,43ย โ‚ฌ61.33%
2013-193,66ย โ‚ฌ-57.14%
2012-451,87ย โ‚ฌ-45.31%
2011-826,27ย โ‚ฌ-420%
2010258,21ย โ‚ฌ-112.9%
2009-2.001ย โ‚ฌ342.86%
2008-451,87ย โ‚ฌ-30%
2007-645,53ย โ‚ฌ-0%
2006-645,53ย โ‚ฌ150%
2005-258,21ย โ‚ฌ-0%
2004-258,21ย โ‚ฌ-75%
2003-1.033ย โ‚ฌ-54.29%
2002-2.259ย โ‚ฌ-31.37%
2001-3.292ย โ‚ฌ15.91%
2000-2.840ย โ‚ฌ-13.58%
1999-3.287ย โ‚ฌ-29.73%
1998-4.677ย โ‚ฌ-26%
1997-6.320ย โ‚ฌ-13.79%
1996-7.331ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,52ย โ‚ฌ-273.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
12,46ย โ‚ฌ-387.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-1,97ย โ‚ฌ-54.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-20,48ย โ‚ฌ 372.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
1,18ย โ‚ฌ-127.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
-1,49ย โ‚ฌ-65.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-0,15ย โ‚ฌ-96.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-1.409ย โ‚ฌ 32,375.20%๐Ÿ‡บ๐Ÿ‡ธ USA